United Therapeutics Corporation
United Therapeutics Corporation (UTHR) — Form 144: Proposed sale of shares
AI-generated summary
Director Christopher Patusky of United Therapeutics Corporation proposed to sell 1,210 shares of common stock with an aggregate market value of $701,800 through broker Morgan Stanley Smith Barney LLC Executive Financial Services. The shares were acquired through a stock option exercise on November 9, 2026. The proposed sale date is November 9, 2026.
Key facts
- Seller
- CHRISTOPHER PATUSKY
- Relationship
- Director
- Shares to sell
- 1,210
- Market value
- $701,800.00
- Approximate sale date
- Nov 9, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Nov 9, 2026 · Stock Option Exercise
More UTHR filings
- 4
Filed Nov 9, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.